Skip to Content

Vivotif Berna Vaccine (typhoid vaccine, live) Disease Interactions

There are 2 disease interactions with Vivotif Berna Vaccine (typhoid vaccine, live):

Major

Typhoid Oral Vaccine (Live) (Includes Vivotif Berna Vaccine) ↔ Fever

Severe Potential Hazard, Moderate plausibility

Applies to: Fever, Immunodeficiency

The oral typhoid vaccine should not be administered to persons during an acute febrile illness. Safety of the vaccine has not been demonstrated in persons deficient in their ability to mount a humoral or cell-mediated immune response, due to either a congenital or acquired immunodeficient state including treatment with immunosuppressive or antimitotic drugs. The vaccine should not be administered to these persons regardless of benefits.

Major

Typhoid Oral Vaccine (Live) (Includes Vivotif Berna Vaccine) ↔ Gi Illness

Severe Potential Hazard, Moderate plausibility

Applies to: Infectious Diarrhea/Enterocolitis/Gastroenteritis

The oral typhoid vaccine should not be taken during an acute gastrointestinal illness. The vaccine should not be administered to individuals receiving sulfonamides and antibiotics since these agents may be active against the vaccine strain and prevent a sufficient degree of multiplication to occur in order to induce a protective immune response. Postpone taking the vaccine if persistent diarrhea or vomiting is occurring. Not all recipients will be fully protected against typhoid fever. Advise all persons that vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms, i.e. travelers should take all necessary precautions to avoid contact or ingestion of potentially contaminated food or water.

Vivotif Berna Vaccine (typhoid vaccine, live) drug Interactions

There are 342 drug interactions with Vivotif Berna Vaccine (typhoid vaccine, live)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide